Distinct human circulating NKp30 <sup>+</sup> FcεRIγ <sup>+</sup> CD8 <sup>+</sup> T cell population exhibiting high natural killer-like antitumor potentialMargareta P. Correia, Adelheid Cerwenka, Ana Stojanovic et al.|Proceedings of the National Academy of Sciences|2018Cited by 71
TGF-β2 silencing to target biliary-derived liver diseasesAnne Dropmann, Nadja M. Meindl‐Beinker, Michel Janicot et al.|Gut|2020Cited by 43
Vitamin A‐treated natural killer cells reduce interferon‐gamma production and support regulatory T‐cell differentiationMingeum Jeong, Ana Stojanovic|European Journal of Immunology|2024Cited by 5
TGF-beta 2 als therapeutische Zielstruktur bei cholestatischer LeberfibroseAnne Dropmann, NM Meindl-Beinker, Steven Dooley et al.|Zeitschrift für Gastroenterologie|2019Cited by 0
A distinct human NKp30+FcɛRIγ+CD8+ T cell population exhibiting high NK-like anti-tumor potentialMargareta P. Correia, Adelheid Cerwenka, Ana Stojanovic et al.|The Journal of Immunology|2018Cited by 0